title: Further evidence of favorable effects of gemfibrozil on the lipid profile in renal allograft recipients.
authors.forename: E
authors.initials: E
authors.lastname: Ok
authors.forename: S
authors.initials: S
authors.lastname: Kursat
authors.forename: M
authors.initials: M
authors.lastname: Alev
authors.forename: M
authors.initials: M
authors.lastname: Tobu
authors.forename: Y
authors.initials: Y
authors.lastname: Tokat
authors.forename: F
authors.initials: F
authors.lastname: Akcicek
authors.forename: C
authors.initials: C
authors.lastname: Hoscoskun
authors.forename: A
authors.initials: A
authors.lastname: Basci
mesh_terms: D000328:Adult; D005260:Female; D015248:Gemfibrozil / Q000627:therapeutic use*; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000502:physiology*; D008055:Lipids / Q000097:blood*; D008297:Male
chemical_list: D000960:Hypolipidemic Agents; D008055:Lipids; D015248:Gemfibrozil